T-29 Predictors of virologic response with telaprevir-based combination treatment in HCV genotype 1-infected patients with prior peginterferon/ribavirin treatment failure: post-hoc analysis of the phase III REALIZE study

Authors :: I. Lonjon-Domanec
Steven Roberts
Stanislas Pol
Andrzej Horban
Thomas Berg
James Witek
S. Zeuzem
G. Picchio
R. Focaccia
P. Andreone
Ralph DeMasi
E.J. Lawitz
Z.M. Younossi
Graham R. Foster
Moisés Diago
Source :: Digestive and Liver Disease. 44:S24
Publication Year :: 2012
Publisher :: Elsevier BV, 2012.

Subjects :: Oncology
medicine.medical_specialty
Hepatology
business.industry
Gastroenterology
PEGINTERFERON/RIBAVIRIN
Treatment failure
Telaprevir
Combined treatment
Hcv genotype 1
Internal medicine
Virologic response
Post-hoc analysis
medicine
business
medicine.drug

Tools